NO964007L - Kombinasjoner av trombolytisk aktive proteiner og antikoagulanter samt anvendelse derav - Google Patents

Kombinasjoner av trombolytisk aktive proteiner og antikoagulanter samt anvendelse derav

Info

Publication number
NO964007L
NO964007L NO964007A NO964007A NO964007L NO 964007 L NO964007 L NO 964007L NO 964007 A NO964007 A NO 964007A NO 964007 A NO964007 A NO 964007A NO 964007 L NO964007 L NO 964007L
Authority
NO
Norway
Prior art keywords
thrombolytically
thrombolytically active
anticoagulants
combinations
anticoagulant
Prior art date
Application number
NO964007A
Other languages
English (en)
Other versions
NO964007D0 (no
NO316584B1 (no
Inventor
Ulrich Martin
Stephan Fischer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22811809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO964007(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO964007D0 publication Critical patent/NO964007D0/no
Publication of NO964007L publication Critical patent/NO964007L/no
Publication of NO316584B1 publication Critical patent/NO316584B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19964007A 1994-03-25 1996-09-24 Kombinasjon av trombolytisk aktive proteiner og antikoagulanter samt anvendelse derav NO316584B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/217,618 US5510330A (en) 1994-03-25 1994-03-25 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
PCT/EP1995/001061 WO1995026202A1 (en) 1994-03-25 1995-03-22 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof

Publications (3)

Publication Number Publication Date
NO964007D0 NO964007D0 (no) 1996-09-24
NO964007L true NO964007L (no) 1996-11-25
NO316584B1 NO316584B1 (no) 2004-03-01

Family

ID=22811809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964007A NO316584B1 (no) 1994-03-25 1996-09-24 Kombinasjon av trombolytisk aktive proteiner og antikoagulanter samt anvendelse derav

Country Status (21)

Country Link
US (1) US5510330A (no)
EP (2) EP0751785B2 (no)
JP (1) JPH09510439A (no)
KR (1) KR100366982B1 (no)
CN (1) CN1090029C (no)
AT (1) ATE167631T1 (no)
AU (1) AU702470B2 (no)
BR (1) BR9507189A (no)
CA (1) CA2186390A1 (no)
CZ (1) CZ279596A3 (no)
DE (1) DE69503120T3 (no)
DK (1) DK0751785T4 (no)
ES (1) ES2119411T5 (no)
FI (1) FI120182B (no)
MX (1) MX9603925A (no)
NO (1) NO316584B1 (no)
NZ (1) NZ282417A (no)
PL (1) PL182165B1 (no)
RU (1) RU2166326C2 (no)
UA (1) UA41398C2 (no)
WO (1) WO1995026202A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070203520A1 (en) * 1995-06-07 2007-08-30 Dennis Griffin Endovascular filter
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US7550005B2 (en) 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
US7867275B2 (en) * 1995-06-07 2011-01-11 Cook Incorporated Coated implantable medical device method
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US7846202B2 (en) 1995-06-07 2010-12-07 Cook Incorporated Coated implantable medical device
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6750201B1 (en) * 1997-10-17 2004-06-15 The Trustees Of The University Of Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
FI20020197A0 (fi) * 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
US7084118B2 (en) * 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
WO2004006976A1 (en) 2002-07-12 2004-01-22 Cook Incorporated Coated medical device
DE10244847A1 (de) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
AU2005248772B2 (en) * 2004-05-17 2010-11-25 Medtronic, Inc. Point of care heparin determination system
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
TWI482628B (zh) * 2007-10-18 2015-05-01 Lundbeck & Co As H 新穎之血栓溶解病患次群
CN101952309A (zh) * 2007-12-21 2011-01-19 Ifxa有限公司 蛋白酶抑制剂
JP6826040B2 (ja) 2014-11-03 2021-02-03 スロンボリティック・サイエンス・リミテッド・ライアビリティ・カンパニーＴｈｒｏｍｂｏｌｙｔｉｃ Ｓｃｉｅｎｃｅ， Ｌｌｃ 安全かつ効果的な血栓溶解（Ｔｈｒｏｍｂｏｌｙｓｉｓ）のための方法および組成物
KR20160094345A (ko) * 2015-01-30 2016-08-09 고려대학교 산학협력단 베르베논 유도체를 포함하는 재관류 시술의 부작용을 감소 또는 예방하기 위한 조성물
RU2622006C2 (ru) * 2015-06-15 2017-06-08 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) Применение рекомбинантного штамма bacillus subtilis eo-11 вкпм в-11978 в качестве продуцента субтилизиноподобной протеиназы, вещества с тромболитическими и антикоагулянтными свойствами
CN105396127A (zh) * 2015-11-13 2016-03-16 中国人民解放军第四军医大学 一种用于急性心肌梗死的冠状动脉溶栓剂
US11154596B2 (en) 2017-06-16 2021-10-26 Thrombolytic Science, Llc Methods for thrombolysis
CN117683081A (zh) * 2021-09-24 2024-03-12 江西康之康中药科技有限公司 一种降血压肽及其在降血压制品上的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
DK43387A (da) † 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
CA2064231A1 (en) * 1989-07-20 1991-01-21 John M. Maraganore Combinations and methods for treating or preventing thrombotic diseases
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5189019A (en) * 1990-04-23 1993-02-23 Merck & Co., Inc. Antistasin derived anticoagulant protein
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5500411A (en) † 1991-04-16 1996-03-19 Boehringer Mannheim Gmbh Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins
DK0643772T3 (da) † 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber

Also Published As

Publication number Publication date
CN1090029C (zh) 2002-09-04
MX9603925A (es) 1997-04-30
DK0751785T4 (da) 2002-04-15
PL316449A1 (en) 1997-01-20
ES2119411T5 (es) 2002-08-01
NZ282417A (en) 1998-02-26
ATE167631T1 (de) 1998-07-15
EP0850648A2 (en) 1998-07-01
JPH09510439A (ja) 1997-10-21
FI963802A (fi) 1996-09-24
RU2166326C2 (ru) 2001-05-10
EP0751785A1 (en) 1997-01-08
UA41398C2 (uk) 2001-09-17
KR100366982B1 (ko) 2003-08-02
PL182165B1 (pl) 2001-11-30
DE69503120T3 (de) 2003-08-14
DE69503120D1 (de) 1998-07-30
US5510330A (en) 1996-04-23
FI120182B (fi) 2009-07-31
CA2186390A1 (en) 1995-10-05
AU702470B2 (en) 1999-02-25
NO964007D0 (no) 1996-09-24
FI963802A0 (fi) 1996-09-24
AU1951195A (en) 1995-10-17
DE69503120T2 (de) 1998-11-12
DK0751785T3 (da) 1999-04-06
ES2119411T3 (es) 1998-10-01
CZ279596A3 (cs) 1998-01-14
EP0850648A3 (en) 2004-03-31
WO1995026202A1 (en) 1995-10-05
CN1144489A (zh) 1997-03-05
NO316584B1 (no) 2004-03-01
EP0751785B1 (en) 1998-06-24
BR9507189A (pt) 1997-09-09
EP0751785B2 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
NO964007L (no) Kombinasjoner av trombolytisk aktive proteiner og antikoagulanter samt anvendelse derav
ES2168302T3 (es) Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e.
ES2143641T3 (es) Expresion en superficie de una enzima en la terapia genica a base de promedicamentos.
DE68929551D1 (de) Menschliche DNase
DE69524864D1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
ATE88900T1 (de) Konjugate von interferon alpha mit immunglobulinen.
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
IT8819693A0 (it) Apparecchio atto ad operare, in modo pressoche' istantaneo, la distruzione completa dell'ago di siringhe per iniezione, subito dopo il loro impiego.
DE69233760D1 (de) Inhibitoren der menschlichen Elastase von Neutrophilen
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DE284243T1 (de) Aseptische irrigationsspritze.
ES2093607T3 (es) Rna bicatenario para la correccion de anomalias en complejos inmunes circulantes y en la funcion de los monocitos.
DE69322251T2 (de) Medizinische zusammensetzung
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DE69008513T2 (de) Pharmazeutische formulierung von plasminogenaktivatorproteinen.
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
NO163654C (no) Mikrobobleforloeper i steril, injiserbar enhetsdoseringsform, fremgangsmaate til fremstilling av en vandig suspensjonav mikrobobler og anvendelse av mikrobobleforloeperen for injisering i blodstroemmen hos et levende vesen.
IT9041714A0 (it) Linfa del libro dell'abete rosso (abies picea) per la cura di malattie neoplastiche e da virus in genere
IT8820663A0 (it) Composizione farmaceutica oftalmica ad azione fotoprotettiva.
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
ITBO930131V0 (it) contenitore di sicurezza per aghi medicali gia' utilizzati, in particolare per aghi farfalla.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

MM1K Lapsed by not paying the annual fees